| 产品编号 | CFN91723 | |
| CAS编号 | 73-32-5 | |
| 分子式 = 分子量 | C6H13NO2 = 131.18 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| L-异亮氨酸 | CFN91723 | 73-32-5 | 10mg | QQ客服:1413575084 |
| L-异亮氨酸 | CFN91723 | 73-32-5 | 20mg | QQ客服:1413575084 |
| L-异亮氨酸 | CFN91723 | 73-32-5 | 50mg | QQ客服:1413575084 |
| L-异亮氨酸 | CFN91723 | 73-32-5 | 100mg | QQ客服:1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | L-Isoleucine often impacts muscle repair function, cirrhosis, obesity, cardiovascular disease, glucose and lipid metabolism, blood glucose levels and other conditions. L-Isoleucine administration can regulate the inflammatory response to protect against pathogens in vivo and in vitro, making it for research in dextran sulfate sodium (DSS) (HY-116282) -induced colitis. IC50 & Target: Human Endogenous Metabolite |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 7.6231 mL | 38.1156 mL | 76.2311 mL | 152.4623 mL | 190.5778 mL |
| 5 mM | 1.5246 mL | 7.6231 mL | 15.2462 mL | 30.4925 mL | 38.1156 mL |
| 10 mM | 0.7623 mL | 3.8116 mL | 7.6231 mL | 15.2462 mL | 19.0578 mL |
| 50 mM | 0.1525 mL | 0.7623 mL | 1.5246 mL | 3.0492 mL | 3.8116 mL |
| 100 mM | 0.0762 mL | 0.3812 mL | 0.7623 mL | 1.5246 mL | 1.9058 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 5-羟基黄酮; 5-Hydroxyflavone | CFN70123 | 491-78-1 | C15H10O3 = 238.2 | 20mg | QQ客服:1457312923 |
| 商陆苷; Ombuoside | CFN92808 | 20188-85-6 | C29H34O16 = 638.6 | 5mg | QQ客服:3257982914 |
| Cynanoside F | CFN91815 | 1800029-50-8 | C41H62O15 = 794.9 | 5mg | QQ客服:215959384 |
| 甲基原薯蓣皂苷; Methyl protodioscin | CFN99585 | 54522-52-0 | C52H86O22 = 1063.23 | 20mg | QQ客服:1413575084 |